There are 2789 resources available
591P - A first-in-human study of FOR46 in men with metastatic castration resistant prostate cancer (mCRPC)
Presenter: Rahul Aggarwal
Session: ePoster Display
592P - Bipolar androgen therapy (BAT) plus olaparib in men with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Michael Schweizer
Session: ePoster Display
593P - Pain efficacy with radium-223 (Ra-223) in the REASSURE global, prospective, observational study of men with metastatic castration-resistant prostate cancer (mCRPC)
Presenter: Celestia Higano
Session: ePoster Display
594P - Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational study
Presenter: Holger Palmedo
Session: ePoster Display
560TiP - A phase I/IIa study to evaluate the safety and efficacy of CCS1477, a first in clinic inhibitor of p300/CBP, as monotherapy in patients with selected molecular alterations
Presenter: Simon Crabb
Session: ePoster Display
55P - Integrative genomic analysis identified primary cilium-associated genes by as novel key genes in biliary tract cancer (BTC)
Presenter: Massimiliano Salati
Session: ePoster Display
56P - Serum protein signatures as potential novel diagnostic biomarkers for biliary tract cancer
Presenter: Troels Christensen
Session: ePoster Display
57P - The characteristics of IDH mutations in Chinese bile duct carcinoma patients
Presenter: Yuwen Wang
Session: ePoster Display
58P - Intrahepatic cholangiocarcinoma (iCCA) hidden amongst the unknown: A retrospective analysis of cancer of unknown primary (CUP) cases from a tertiary cancer centre
Presenter: Alicia-Marie Conway
Session: ePoster Display
59TiP - Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Presenter: Jennifer Knox
Session: ePoster Display